C. Álvarez, E. Gómez, M. Simón, C. Govantes, P. Guerra, J. Frías u. a.: Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake. In: European Journal of Clinical Pharmacology. Band68, Nr.7, 2012, S.1043–1047, doi:10.1007/s00228-012-1215-8, PMID 22294059.
K. Makarounas-Kirchmann, S. Glover-Koudounas, P. Ferrari: Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. In: Clin Ther. Band31, Nr.8, August 2009, S.1652–1663, doi:10.1016/j.clinthera.2009.08.010, PMID 19808126.
nih.gov
ncbi.nlm.nih.gov
C. Álvarez, E. Gómez, M. Simón, C. Govantes, P. Guerra, J. Frías u. a.: Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake. In: European Journal of Clinical Pharmacology. Band68, Nr.7, 2012, S.1043–1047, doi:10.1007/s00228-012-1215-8, PMID 22294059.
K. Chen, J. Zhang, S. Liu, D. Zhang, Y. Teng, C. Wei, B. Wang, X. Liu, G. Yuan, R. Zhang, W. Zhao, R. Guo: Simultaneous determination of lercanidipine, benazepril and benazeprilat in plasma by LC-MS/MS and its application to a toxicokinetics study. In: J Chromatogr B Analyt Technol Biomed Life Sci. 899, 15. Jun 2012, S. 1–7, PMID 22622066
J. Fiori, R. Gotti, C. Bertucci, V. Cavrini: Investigation on the photochemical stability of lercanidipine and its determination in tablets by HPLC-UV and LC-ESI-MS/MS. In: J Pharm Biomed Anal. 41(1), 11. Apr 2006, S. 176–181. PMID 16378707
K. Makarounas-Kirchmann, S. Glover-Koudounas, P. Ferrari: Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. In: Clin Ther. Band31, Nr.8, August 2009, S.1652–1663, doi:10.1016/j.clinthera.2009.08.010, PMID 19808126.
A. Schattner: Lercanidipine-associated nocturia. In: Q J Med. 104, 2011, S. 463. PMID 21349908
